VICTOR KRASNYKH to Genetic Therapy
This is a "connection" page, showing publications VICTOR KRASNYKH has written about Genetic Therapy.
Connection Strength
1.063
-
Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43. Oncotarget. 2016 Aug 16; 7(33):53414-53429.
Score: 0.314
-
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer. J Virol. 2008 Jan; 82(2):630-7.
Score: 0.171
-
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res. 1999 Sep; 5(9):2571-9.
Score: 0.097
-
Development of a targeted gene vector platform based on simian adenovirus serotype 24. J Virol. 2010 Oct; 84(19):10087-101.
Score: 0.051
-
Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther. 2008 May; 16(5):886-92.
Score: 0.044
-
HSV-1 virions engineered for specific binding to cell surface receptors. Mol Ther. 2004 Mar; 9(3):419-27.
Score: 0.033
-
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology. 2003 Oct; 125(4):1203-18.
Score: 0.032
-
Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement. J Gastrointest Surg. 2003 Mar-Apr; 7(3):364-71.
Score: 0.031
-
Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein. J Hepatol. 2002 Nov; 37(5):660-8.
Score: 0.030
-
The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer. 2002 Sep; 38(14):1917-26.
Score: 0.030
-
Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res. 2002 Aug 01; 62(15):4273-81.
Score: 0.030
-
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res. 2002 Mar 01; 62(5):1266-70.
Score: 0.029
-
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther. 2001 Jul; 8(13):969-76.
Score: 0.027
-
Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid. Hum Gene Ther. 2000 Aug 10; 11(12):1657-69.
Score: 0.026
-
Genetic targeting of adenoviral vectors. Mol Ther. 2000 May; 1(5 Pt 1):391-405.
Score: 0.025
-
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol. 1996 Oct; 70(10):6839-46.
Score: 0.020
-
Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters. Proc Natl Acad Sci U S A. 2013 Mar 05; 110(10):E869-77.
Score: 0.015
-
Cell cycle arrest and apoptosis induced by SART-1 gene transduction. Anticancer Res. 2005 May-Jun; 25(3B):1983-90.
Score: 0.009
-
Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo. Virology. 2004 Mar 01; 320(1):121-34.
Score: 0.008
-
Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res. 2003 Mar 15; 63(6):1262-9.
Score: 0.008
-
Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells. 2003; 21(4):389-404.
Score: 0.008
-
Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology. 2002 May; 223(2):417-25.
Score: 0.007
-
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin Cancer Res. 2002 Jan; 8(1):275-80.
Score: 0.007
-
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998 Dec; 72(12):9706-13.
Score: 0.006
-
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med (Berl). 1996 Aug; 74(8):455-62.
Score: 0.005